Lifecore Biomedical Balance Sheet

Financials in millions USD. Fiscal year is June - May.

Millions USD. Fiscal year is Jun - May.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '25 May 25, 2025	May '24 May 26, 2024	May '23 May 28, 2023	May '22 May 29, 2022	May '21 May 30, 2021
Cash & Equivalents	8.27	8.46	19.09	0.99	1.16
Cash & Short-Term Investments	8.27	8.46	19.09	0.99	1.16
Cash Growth	-2.33%	-55.67%	1826.44%	-14.49%	221.94%
Accounts Receivable	35.67	31.15	29.02	38.31	41.43
Receivables	43.67	31.15	29.02	38.31	41.43
Inventory	32.29	39.98	40.84	36	63.08
Prepaid Expenses	1.45	1.44	4.02	1.05	4.54
Other Current Assets	-	-	0.9	40.31	38.12
Total Current Assets	85.68	81.03	93.88	116.67	148.32
Property, Plant & Equipment	123.48	126.36	138.67	124.22	137.38
Goodwill	13.88	13.88	13.88	13.88	33.92
Other Intangible Assets	4.2	4.2	4.2	4.2	25.63
Long-Term Deferred Charges	-	-	1.4	-	-
Other Long-Term Assets	12.1	28.48	1.52	15.73	157.67
Total Assets	239.34	253.96	253.55	274.7	502.92
Accounts Payable	8.22	16.33	22.1	12.95	16.3
Accrued Expenses	8.06	9.67	11.29	15.42	11.71
Short-Term Debt	-	-	-	40	29
Current Portion of Long-Term Debt	3.44	0.94	0.58	98.18	-
Current Portion of Leases	0.39	3.96	1.27	4.37	1.6
Current Unearned Revenue	3.42	2.11	4.05	0.92	0.64
Other Current Liabilities	6.66	5.85	-	4.74	42.64
Total Current Liabilities	30.18	38.87	39.29	176.58	101.89
Long-Term Debt	127	123.73	101.07	-	166.64
Long-Term Leases	-	-	9.71	7.66	20.36
Long-Term Unearned Revenue	-	-	2.94	-	-
Long-Term Deferred Tax Liabilities	-	-	0.38	0.13	6.14
Other Long-Term Liabilities	34.73	37.46	65.07	2.52	5.12
Total Liabilities	191.91	200.06	218.46	186.88	300.14
Common Stock	0.04	0.03	0.03	0.03	0.03
Additional Paid-In Capital	206.54	177.81	174.28	167.35	165.53
Retained Earnings	-205.24	-166.52	-178.54	-78.97	38.58
Comprehensive Income & Other	-	-	-	-0.59	-1.36
Total Common Equity	1.34	11.32	-4.23	87.82	202.78
Shareholders' Equity	47.43	53.9	35.09	87.82	202.78
Total Liabilities & Equity	239.34	253.96	253.55	274.7	502.92
Total Debt	130.82	128.63	112.62	150.2	217.6
Net Cash (Debt)	-122.56	-120.17	-93.53	-149.21	-216.44
Net Cash Per Share	-3.52	-3.28	-3.12	-5.06	-7.39
Filing Date Shares Outstanding	37.41	30.9	30.55	29.6	29.46
Total Common Shares Outstanding	37.03	30.56	30.32	29.51	29.33
Working Capital	55.5	42.16	54.59	-59.91	46.43
Book Value Per Share	0.04	0.37	-0.14	2.98	6.91
Tangible Book Value	-16.75	-6.77	-22.31	69.74	143.24
Tangible Book Value Per Share	-0.45	-0.22	-0.74	2.36	4.88
Land	3.74	3.74	3.74	3.71	3.67
Buildings	63.73	62.87	56.79	54.56	47.88
Machinery	71.19	70.93	77.36	72.55	74.35
Construction In Progress	42.23	39.15	45.59	26.89	31.38
Leasehold Improvements	-	-	4.02	4.02	6.47

Source: S&P Global Market Intelligence. Standard template. Financial Sources.